Asbestos and the lung in the 21st century: an update

The asbestos‐related disorders (ARDs) are currently of significant occupational and public health concern. Asbestos usage has been banned in most developed countries, but asbestos is still used in many developing countries and the number of cases of ARDs worldwide is rising. Many countries are now experiencing an epidemic of ARDs that is the legacy of occupational exposure in the 1960s–1980s because of the long latency period between asbestos exposure and manifestation of disease. It is likely that asbestos‐related mortality and morbidity will continue to increase. Although the most feared complications of asbestos inhalation are the malignant conditions such as mesothelioma and lung cancer, asbestos inhalation more frequently results in benign conditions such as pleural plaques, diffuse pleural thickening, and asbestosis (pulmonary fibrosis due to asbestos exposure). Over recent years, there have been changes in the epidemiology of mesothelioma, in clinical management of ARDs and developments in new techniques for early detection of malignancy. This review provides an update on the respiratory manifestations of asbestos exposure and also considers advances in screening methods that may affect future management in the workplace.

[1]  D. Yates,et al.  Asbestos-related bilateral diffuse pleural thickening: natural history of radiographic and lung function abnormalities. , 1996, American journal of respiratory and critical care medicine.

[2]  D. Yates,et al.  Journal of Occupational Medicine and Toxicology Clinical Consequences of Asbestos-related Diffuse Pleural Thickening: a Review , 2008 .

[3]  A. Darnton,et al.  Projection of mesothelioma mortality in Britain using Bayesian methods , 2010, British Journal of Cancer.

[4]  Tsun-Jen Cheng,et al.  Global Magnitude of Reported and Unreported Mesothelioma , 2011, Environmental health perspectives.

[5]  V. Jeebun,et al.  The presentation and natural history of asbestos-induced diffuse pleural thickening. , 2012, Occupational medicine.

[6]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[7]  Eun‐Kee Park,et al.  Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study. , 2008, American journal of respiratory and critical care medicine.

[8]  H. Pass,et al.  Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  BTS statement on malignant mesothelioma in the UK, 2007 , 2007, Thorax.

[10]  D. Lynch,et al.  Conventional and high resolution computed tomography in the diagnosis of asbestos-related diseases. , 1989, Radiographics : a review publication of the Radiological Society of North America, Inc.

[11]  H. Kindler,et al.  Update on malignant pleural mesothelioma. , 2011, Seminars in respiratory and critical care medicine.

[12]  J. Leigh,et al.  After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004. , 2004, Pathology.

[13]  Klinikum Westfalen,et al.  OCCUPATIONAL SAFETY AND HEALTH SERIES No . 22 ( Rev . ) GUIDELINES FOR THE USE OF ILO INTERNATIONAL CLASSIFICATION OF RADIOGRAPHS OF PNEUMOCONIOSES , 2009 .

[14]  T. Autti,et al.  Chest CT screening of asbestos-exposed workers: lung lesions and incidental findings , 2006, European Respiratory Journal.

[15]  A. Musk,et al.  Predicting survival in malignant mesothelioma , 2009, European Respiratory Journal.

[16]  J. Huggins,et al.  Causes and management of pleural fibrosis , 2004, Respirology.

[17]  F. Galateau-Sallé,et al.  Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of american pathologists and pulmonary pathology society. , 2010, Archives of pathology & laboratory medicine.

[18]  F. Laurent,et al.  Do asbestos-related pleural plaques on HRCT scans cause restrictive impairment in the absence of pulmonary fibrosis? , 2011, Thorax.

[19]  J. Peto,et al.  Occupational, domestic and environmental mesothelioma risks in the British population: a case–control study , 2009, British Journal of Cancer.

[20]  D. Yates,et al.  Projected mesothelioma incidence in men in New South Wales , 2007, Occupational and Environmental Medicine.

[21]  B. Felson,et al.  Rounded atelectasis. , 1980, AJR. American journal of roentgenology.

[22]  A. Rossi,et al.  Treatment of patients with small-cell lung cancer: from meta-analyses to clinical practice. , 2013, Cancer treatment reviews.

[23]  Y. Inoue,et al.  High-resolution CT of asbestosis and idiopathic pulmonary fibrosis. , 2003, AJR. American journal of roentgenology.

[24]  A. Alavi,et al.  Current Evidence Base of FDG-PET/CT Imaging in the Clinical Management of Malignant Pleural Mesothelioma: Emerging Significance of Image Segmentation and Global Disease Assessment , 2011, Molecular Imaging and Biology.

[25]  F. Galateau-Sallé,et al.  Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma , 2009, European Respiratory Journal.

[26]  G. Giaccone,et al.  Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Collegium Ramazzini,et al.  Asbestos Is Still With Us: Repeat Call for a Universal Ban , 2010, Archives of environmental & occupational health.

[28]  M. Copin,et al.  Utility of Osteopontin and Serum Mesothelin in Malignant Pleural Mesothelioma Diagnosis and Prognosis Assessment , 2007, Clinical Cancer Research.

[29]  Y. C. Lee,et al.  Benign asbestos pleural diseases. , 2003, Current opinion in pulmonary medicine.

[30]  J. Pilling,et al.  Integrated Positron Emission Tomography-Computed Tomography Does Not Accurately Stage Intrathoracic Disease of Patients Undergoing Trimodality Therapy for Malignant Pleural Mesothelioma , 2010, The Thoracic and cardiovascular surgeon.

[31]  G. Hillerdal.  Rounded atelectasis. Clinical experience with 74 patients. , 1989, Chest.

[32]  P. Batra,et al.  Rounded atelectasis : Atelectasis, Part 2 , 1996 .

[33]  H. Weill,et al.  Diagnosis and initial management of nonmalignant diseases related to asbestos. , 2005, American journal of respiratory and critical care medicine.

[34]  T. McLoud,et al.  Normal chest roentgenograms in chronic diffuse infiltrative lung disease. , 1978, The New England journal of medicine.

[35]  M. Scarci,et al.  Does positron emission tomography offer prognostic information in malignant pleural mesothelioma? , 2011, Interactive cardiovascular and thoracic surgery.

[36]  D. Yates,et al.  Chest pain in asbestos and silica-exposed workers. , 2011, Occupational medicine.

[37]  Dario Mirabelli,et al.  Cancer Mortality and Incidence of Mesothelioma in a Cohort of Wives of Asbestos Workers in Casale Monferrato, Italy , 2007, Environmental health perspectives.

[38]  V. Rusch,et al.  Malignant mesothelioma in Australia , 2006 .

[39]  J. Ajani,et al.  Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers. , 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

[40]  S. Skates,et al.  Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[41]  J. van der Zee,et al.  Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura--a single-institution experience with 189 patients. , 1999, International journal of radiation oncology, biology, physics.

[42]  D. Yates,et al.  Surveillance of Australian workplace Based Respiratory Events (SABRE) in New South Wales. , 2010, Occupational medicine.

[43]  R. Lilis,et al.  Pulmonary fibrosis in asbestos insulation workers with lung cancer: a radiological and histopathological evaluation. , 1987, British journal of industrial medicine.

[44]  T. Driscoll,et al.  Malignant Mesothelioma in Australia, 1945–2002 , 2003, International journal of occupational and environmental health.

[45]  B. Musk,et al.  Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation , 2011, The Medical journal of Australia.

[46]  M. Tsao,et al.  Soluble mesothelin-related Peptide and osteopontin as markers of response in malignant mesothelioma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  L. Palmer,et al.  Chest pain in asbestos-exposed individuals with benign pleural and parenchymal disease. , 2000, American journal of respiratory and critical care medicine.

[48]  G. Reid,et al.  Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[49]  J. Peto,et al.  Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study , 2011, The Lancet. Oncology.

[50]  D. Waller,et al.  Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion. , 1995, Chest.

[51]  Pierre Saintigny,et al.  Recent advances in non-small cell lung cancer biology and clinical management. , 2012, Discovery medicine.

[52]  Eun‐Kee Park,et al.  Osteopontin Levels in an Asbestos-Exposed Population , 2009, Clinical Cancer Research.

[53]  Deborah H Yates,et al.  A breath test for malignant mesothelioma using an electronic nose , 2011, European Respiratory Journal.

[54]  Marty S Kanarek,et al.  Mesothelioma from chrysotile asbestos: update. , 2011, Annals of epidemiology.

[55]  A. Darnton,et al.  The effect of smoking on the risk of lung cancer mortality for asbestos workers in Great Britain (1971-2005). , 2011, The Annals of occupational hygiene.

[56]  D. Brizel,et al.  National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .

[57]  B. Price,et al.  Time trend of mesothelioma incidence in the United States and projection of future cases: An update based on SEER data for 1973 through 2005 , 2009, Critical reviews in toxicology.

[58]  G. Hillerdal,et al.  Benign asbestos pleural effusion: 73 exudates in 60 patients. , 1987, European journal of respiratory diseases.

[59]  Zhandong Liu,et al.  Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. , 2005, The New England journal of medicine.

[60]  Dorsett D. Smith.  Diagnosis and Initial Management of Nonmalignant Diseases Related to Asbestos , 2003 .

[61]  Martin Krapcho,et al.  SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations) , 2012 .

[62]  Claude Denham,et al.  Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  G. Gamsu,et al.  Causes of pulmonary impairment in asbestos-exposed individuals with diffuse pleural thickening. , 1996, American journal of respiratory and critical care medicine.

[64]  V. Dolžan,et al.  Soluble Mesothelin-Related Peptides Levels in Patients with Malignant Mesothelioma , 2012, Disease markers.

[65]  T. McLoud,et al.  Prevalence and incidence of benign asbestos pleural effusion in a working population. , 1982, JAMA.

[66]  S. Dalichau,et al.  Verbesserung von Nachhaltigkeitseffekten in der ambulanten pneumologischen Rehabilitation unter besonderer Berücksichtigung der Sporttherapie , 2010 .

[67]  G. Benke,et al.  Australian Mesothelioma Registry 1st Annual Report , 2011 .

[68]  Dennis J Paustenbach,et al.  Evaluation of take home (para-occupational) exposure to asbestos and disease: a review of the literature , 2012, Critical reviews in toxicology.

[69]  V. Rusch.  A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. , 1995, Chest.

[70]  D. Nowak,et al.  Long-Term Efficacy of Pulmonary Rehabilitation in Patients with Occupational Respiratory Diseases , 2012, Respiration.

[71]  R. Attanoos,et al.  Asbestos: when the dust settles an imaging review of asbestos-related disease. , 2002, Radiographics : a review publication of the Radiological Society of North America, Inc.